• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David Buchholz, MD; Steven Kariya, MD
The Johns Hopkins Hospital Baltimore, MD 21205

Arch Neurol. 1983;40(8):528-529.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The reports by Indo and Ando¹ and others² of metoclopramide-induced parkinsonism suggest that this adverse effect is more common than previously suspected. We report its occurrence in a young patient—the first such report, to our knowledge—and emphasize certain guidelines for metoclopramide therapy.

Report of a Case.

—A 33-year-old woman with insulin-dependent diabetes mellitus was admitted to The Johns Hopkins Hospital, Baltimore, with symptoms of diabetic gastroparesis, which had been treated for four months with oral metoclopramide hydrochloride, at dosages of 10 to 40 mg four times a day. The patient was seen in neurologic consultation for a movement disorder of several months' duration. Examination revealed parkinsonism with slow vertical saccades, masked facies, akinesia and bradykinesia, cogwheel rigidity, shuffling gait, and postural instability. No tremor or dyskinesia was noted. The creatinine level was mildly elevated (range, 1.5 to 2.0 mg/dL) because of chronic diabetic nephropathy. Medications . . . [Full Text PDF of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?